En direct

Mar 2015 Blood cancer journal

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

Auteurs

Collette Y, Prébet T, Goubard A, Adélaïde J, Castellano R, Carbuccia N, Guille A, Arnoulet C, Charbonier A, Mozziconacci MJ, Birnbaum D, Chaffanet M, Vey N